JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Apyx Medical Corporation to Participate in the JMP Securities Life Sciences Conference
-
Mission Secure Named a JMP Securities "Elite 80" Cybersecurity Company for 2021
-
Neuronetics to Present at The JMP Securities Life Sciences Conference
-
Cambium Networks (CMBM) Prices 2M Share Secondary Offering at $48
-
Cambium Networks Corporation Announces Pricing of Secondary Offering
-
Cambium Networks Corporation Announces Pricing of Secondary Offering
-
PolyPid to Present at Upcoming Healthcare Investor Conferences
-
Prelude Therapeutics Announces Participation at Two Upcoming Virtual Investor Conferences
-
Karuna Therapeutics to Present at Upcoming Investor Conferences
-
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
-
Relay Therapeutics to Participate in Two Upcoming Investor Conferences
-
LogicBio Therapeutics to Participate in Upcoming Investor Conferences
-
Apollo Endosurgery to Present at June Investor Conferences
-
Myovant Sciences to Present at Upcoming Investor Conferences
-
Myovant Sciences to Present at Upcoming Investor Conferences
-
Iovance Biotherapeutics to Present at Upcoming Conferences
-
Iovance Biotherapeutics to Present at Upcoming Conferences
-
Crescendo to participate in upcoming investor conferences
-
argenx to Present at Upcoming Investor Conferences
-
argenx to Present at Upcoming Investor Conferences
-
Sprinklr Files Registration Statement for Proposed Initial Public Offering
-
EverCommerce Files Registration Statement for Proposed Initial Public Offering
-
EverCommerce Files Registration Statement for Proposed Initial Public Offering
-
Halozyme to Present at Upcoming Investor Conferences
-
Finch Therapeutics to Present at Upcoming Virtual Investor Conferences
-
Finch Therapeutics to Present at Upcoming Virtual Investor Conferences
-
Travere Therapeutics to Present at Upcoming Investor Conferences
-
Travere Therapeutics to Present at Upcoming Investor Conferences
-
Adamas to Present at Upcoming June Conferences
-
eFFECTOR Therapeutics and Locust Walk Acquisition (LWAC) Announce Merger Agreement
-
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies
-
eFFECTOR Therapeutics and Locust Walk Acquisition Corp. Announce Merger Agreement to Create Publicly Listed, Next-Generation Oncology Company Developing New Class of Cancer Therapies
-
Yumanity Therapeutics to Present at Upcoming Virtual Investor Conferences
-
Rezolute to Participate in Upcoming Virtual Healthcare Conferences
-
Rezolute to Participate in Upcoming Virtual Healthcare Conferences
-
Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences in June
-
Bicycle Therapeutics to Participate in Upcoming Virtual Investor Conferences
-
Deciphera Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
-
Invesco Mortage Capital (IVR) Prices Public Offering of Common Stock for Gross Proceeds of $128.63M
-
Invesco Mortgage Capital Inc. Announces Pricing of Public Offering of Common Stock
-
Sensorion to Attend Two Conferences in June 2021
-
ERYTECH to Participate in Upcoming Virtual Investor Conferences in June
-
ERYTECH to Participate in Upcoming Virtual Investor Conferences in June
-
JMP Group Announces Partial Redemption of 7.25% Senior Notes Due 2027
-
Invesco Mortage Capital (IVR) Announces 37.5M Share Public Offering of Common Stock
-
Invesco Mortgage Capital Inc. Announces Public Offering of Common Stock
-
Global-e Announces Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Cortexyme to Present at Investor Conferences in June 2021
-
Arbutus to Participate in Upcoming Investor Conferences
-
Ocular Therapeutixâ„¢ to Participate at Three Upcoming Investor Conferences

